SCHEMBL8502484

SCHEMBL8502484

COc1ccc(C(=O)c2ccccc2)cc1Cc1ccn[nH]c1=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 3/20 0.48
▸ CYP1A2 P05177 2/20 0.48
▸ CYP2C19 P33261 2/20 0.48
▸ CYP2D6 P10635 1/20 0.48
▸ TACR1 P25103 1/20 0.46
▸ PTGS1 P23219 1/20 0.44
▸ PTGS2 P35354 1/20 0.44
▸ ACHE P22303 4/20 0.42
▸ BCHE P06276 3/20 0.42
▸ TSHR P16473 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ GAA P10253 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ NOD2 Q9HC29 1/20 0.41
▸ ATM Q13315 1/20 0.41
▸ MAPT P10636 3/20 0.40
▸ CYP3A4 P08684 2/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ HSD17B10 Q99714 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8504696 0.84 PKM (0.36) HPGDCYP1A2CYP2C19TSHRALDH1A1
SCHEMBL8505814 0.84 ADRB2 (0.42) HPGDCYP1A2CYP2C19CYP2D6TSHR
SCHEMBL8504905 0.83 ALDH1A1 (0.40) HPGDCYP1A2CYP2C19CYP2D6TSHR
SCHEMBL8502095 0.80 ROCK2 (0.39) CYP1A2CYP2C19ALDH1A1GAAMAPT
SCHEMBL7590521 0.77 HPGD (0.48) HPGDCYP1A2CYP2C19CYP2D6TACR1
SCHEMBL8526363 0.76 MAPT (0.44) ALDH1A1HTTMAPTLMNA
SCHEMBL9364036 0.73 CYP1A2 (0.66) HPGDCYP1A2CYP2C19CYP2D6TACR1
SCHEMBL10703272 0.73 CYP1A2 (0.61) HPGDCYP1A2CYP2C19CYP2D6TACR1
SCHEMBL5110570 0.73 CYP1A2 (0.61) HPGDCYP1A2CYP2C19CYP2D6TACR1
SCHEMBL8505747 0.72 KMT2A (0.45) CYP2C19TSHRALDH1A1GAAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5886178-A ADMINISTERING OF A PROSTAGLANDIN G/H SYNTHASE INHIBITOR TO A PATIENT TO TREAT INFLAMMATORY OR AUTOIMMUNE DISEASES SYNTEX (U.S.A.) INC. (US) 1999-03-23 — — US disclosed
Send feedback